189 related articles for article (PubMed ID: 21691827)
21. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
[No Abstract] [Full Text] [Related]
22. Sclerosing epithelioid fibrosarcoma: cytogenetic analysis of FUS rearrangement.
Yoon N; Kwon JW; Seo SW; Ahn G; Choi YL
Pathol Int; 2012 Jan; 62(1):65-8. PubMed ID: 22192807
[TBL] [Abstract][Full Text] [Related]
23. Sclerosing epithelioid fibrosarcoma presenting as intraabdominal sarcomatosis with a novel EWSR1-CREB3L1 gene fusion.
Stockman DL; Ali SM; He J; Ross JS; Meis JM
Hum Pathol; 2014 Oct; 45(10):2173-8. PubMed ID: 25123073
[TBL] [Abstract][Full Text] [Related]
24. Gastric Sclerosing Epithelioid Fibrosarcoma Harboring a Rare
Memon RA; Granada CNP; Patel C; Manne U; Heslin MJ; Gbolahan OB; Harada S; Diffalha SA
Int J Surg Pathol; 2021 Aug; 29(5):565-570. PubMed ID: 32964769
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.
Mertens F; Fletcher CD; Antonescu CR; Coindre JM; Colecchia M; Domanski HA; Downs-Kelly E; Fisher C; Goldblum JR; Guillou L; Reid R; Rosai J; Sciot R; Mandahl N; Panagopoulos I
Lab Invest; 2005 Mar; 85(3):408-15. PubMed ID: 15640831
[TBL] [Abstract][Full Text] [Related]
26. [A hybrid lesion: Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF)].
Kesrouani C; Zemoura L; Trassard M; Laé M
Ann Pathol; 2016 Oct; 36(5):351-354. PubMed ID: 27641819
[TBL] [Abstract][Full Text] [Related]
27. Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma.
Bartuma H; Möller E; Collin A; Domanski HA; Von Steyern FV; Mandahl N; Mertens F
Cancer Genet Cytogenet; 2010 Jun; 199(2):143-6. PubMed ID: 20471519
[TBL] [Abstract][Full Text] [Related]
28. Primary intracranial low-grade fibromyxoid sarcoma with FUS gene rearrangement.
Chen N; Gong J; Nie L; Chen X; Xu M; Chen M; Zhou Q
Neuropathology; 2015 Aug; 35(4):348-53. PubMed ID: 25828939
[TBL] [Abstract][Full Text] [Related]
29. Sclerosing epithelioid fibrosarcoma: in-depth review of a genetically heterogeneous tumor.
Murshed KA; Al-Bozom I; Ammar A
APMIS; 2021 Aug; 129(8):455-460. PubMed ID: 34048081
[TBL] [Abstract][Full Text] [Related]
30. Unusual histologic variant of a low-grade fibromyxoid sarcoma in a 3-year-old boy with complex chromosomal translocations involving 7q34, 10q11.2, and 16p11.2 and rearrangement of the FUS gene.
Dobin SM; Malone VS; Lopez L; Donner LR
Pediatr Dev Pathol; 2013; 16(2):86-90. PubMed ID: 23075075
[TBL] [Abstract][Full Text] [Related]
31. Sclerosing epithelioid fibrosarcoma of bone: morphological, immunophenotypical, and molecular findings of 9 cases.
Kosemehmetoglu K; Ardic F; Kilpatrick SE; Aydingoz U; Sumathi VP; Michal M
Virchows Arch; 2021 Apr; 478(4):767-777. PubMed ID: 33084978
[TBL] [Abstract][Full Text] [Related]
32. Sclerosing Epithelioid Fibrosarcoma of the Liver in a Pediatric Patient.
Armstrong A; Boulos F; Kulkarni S; Stoll J; Doyle MBM; Khan A; He M
Pediatr Dev Pathol; 2023; 26(2):153-160. PubMed ID: 36748108
[TBL] [Abstract][Full Text] [Related]
33. Low-grade fibromyxoid sarcoma of the extremities: a clinicopathologic study of 24 cases and review of the literature.
Sambri A; Righi A; Tuzzato G; Donati D; Bianchi G
Pol J Pathol; 2018; 69(3):219-225. PubMed ID: 30509048
[TBL] [Abstract][Full Text] [Related]
34. Sclerosing epithelioid fibrosarcoma of bone with hybrid features: clinicopathologic, radiologic, and molecular analysis of three cases.
Suster DI; Gross JM; Fayad L; Wenokor C; Goldsmith JD; Ward A; Early C; Lazano-Calderon S; Klein MJ
Skeletal Radiol; 2024 Feb; 53(2):387-393. PubMed ID: 37524934
[TBL] [Abstract][Full Text] [Related]
35. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases.
Porteus C; Gan Q; Gong Y; Pantanowitz L; Henderson-Jackson E; Saeed-Vafa D; Mela N; Peterson D; Ahmad N; Ahmed A; Bui M
J Am Soc Cytopathol; 2020; 9(6):513-519. PubMed ID: 32624384
[TBL] [Abstract][Full Text] [Related]
36. The clinical significance of the FUS-CREB3L2 translocation in low-grade fibromyxoid sarcoma.
Rose B; Tamvakopoulos GS; Dulay K; Pollock R; Skinner J; Briggs T; Cannon S
J Orthop Surg Res; 2011 Mar; 6():15. PubMed ID: 21406083
[TBL] [Abstract][Full Text] [Related]
37. Low-grade fibromyxoid sarcoma with nuclear pleomorphism arising in the subcutis of a child.
Sedrak MP; Parker DC; Gardner JM
J Cutan Pathol; 2014 Feb; 41(2):134-8. PubMed ID: 24188507
[TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature.
Tsuda Y; Dickson BC; Dry SM; Federman N; Suurmeijer AJH; Swanson D; Sung YS; Zhang L; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Apr; 59(4):217-224. PubMed ID: 31675134
[TBL] [Abstract][Full Text] [Related]
39. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
40. Primary small intestine mesenteric low-grade fibromyxoid sarcoma with foci of atypical epithelioid whorls and diffuse DOG1 expression: a case report.
Huang J; Cohen S; Jour G
Diagn Pathol; 2020 Mar; 15(1):23. PubMed ID: 32164724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
